These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22076292)

  • 1. Celecoxib.
    Dimens Crit Care Nurs; 2001; 20(2):13. PubMed ID: 22076292
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of the selective cyclooxygenase-2 inhibitor celecoxib in the treatment of rheumatoid arthritis and osteoarthritis in Japan.
    Sakamoto C; Soen S
    Digestion; 2011; 83(1-2):108-23. PubMed ID: 21042022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the cardiovascular risk between celecoxib and nonselective nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis and osteoarthritis.
    Hirayama A; Tanahashi N; Daida H; Ishiguro N; Chachin M; Sugioka T; Kawai S;
    Circ J; 2014; 78(1):194-205. PubMed ID: 24152722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial.
    Chan FK; Lanas A; Scheiman J; Berger MF; Nguyen H; Goldstein JL
    Lancet; 2010 Jul; 376(9736):173-9. PubMed ID: 20638563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib: a review of its use in the management of arthritis and acute pain.
    Frampton JE; Keating GM
    Drugs; 2007; 67(16):2433-72. PubMed ID: 17983259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to mechanistically explain the CONDOR study data.
    Spies CM; Stemmler E; Buttgereit F
    Med Hypotheses; 2015 Jan; 84(1):14-9. PubMed ID: 25433956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of rebamipide add-on therapy in arthritic patients with COX-2 selective inhibitor-related gastrointestinal events: a prospective, randomized, open-label blinded-endpoint pilot study by the GLORIA study group.
    Hasegawa M; Horiki N; Tanaka K; Wakabayashi H; Tano S; Katsurahara M; Uchida A; Takei Y; Sudo A
    Mod Rheumatol; 2013 Nov; 23(6):1172-8. PubMed ID: 23306427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of gastroduodenal ulcers during treatment with celecoxib or diclofenac: pooled results from three 12-week trials in Chinese patients with osteoarthritis or rheumatoid arthritis.
    Cheung R; Cheng TT; Dong Y; Lin HY; Lai K; Lau CS; Feng H; Parsons B
    Int J Rheum Dis; 2010 May; 13(2):151-7. PubMed ID: 20536600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effects of cyclooxygenase-2 selective inhibitor Celecoxib on human nephroblastoma].
    Hu XL; Zhao LS; Liu W; Shu JB; Xu L; Wang ZF
    Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):340-1. PubMed ID: 22883675
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemoglobin decreases in NSAID users over time: an analysis of two large outcome trials.
    Goldstein JL; Chan FK; Lanas A; Wilcox CM; Peura D; Sands GH; Berger MF; Nguyen H; Scheiman JM
    Aliment Pharmacol Ther; 2011 Oct; 34(7):808-16. PubMed ID: 21810115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-utility of celecoxib use in different treatment strategies for osteoarthritis and rheumatoid arthritis from the Quebec healthcare system perspective.
    Bessette L; Risebrough N; Mittmann N; Roussy JP; Ho J; Zlateva G
    J Med Econ; 2009 Sep; 12(3):246-58. PubMed ID: 19743942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of duloxetine and celecoxib in osteoarthritis patients.
    Peng X; Wu N; Chen SY; Yu X; Andrews JS; Novick D
    Curr Med Res Opin; 2013 Sep; 29(9):1161-9. PubMed ID: 23777314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Celecoxib decreases prostaglandin E2 concentrations in nipple aspirate fluid from high risk postmenopausal women and women with breast cancer.
    Sauter ER; Qin W; Schlatter L; Hewett JE; Flynn JT
    BMC Cancer; 2006 Oct; 6():248. PubMed ID: 17049084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmented chondroprotective effect of coadministration of celecoxib and rebamipide in the monosodium iodoacetate rat model of osteoarthritis.
    Moon SJ; Park JS; Jeong JH; Yang EJ; Park MK; Kim EK; Park SH; Kim HY; Cho ML; Min JK
    Arch Pharm Res; 2013 Jan; 36(1):116-24. PubMed ID: 23338062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis.
    Goldenberg MM
    Clin Ther; 1999 Sep; 21(9):1497-513; discussion 1427-8. PubMed ID: 10509845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Celecoxib impairs heart development via inhibiting cyclooxygenase-2 activity in zebrafish embryos.
    Xu DJ; Bu JW; Gu SY; Xia YM; Du JL; Wang YW
    Anesthesiology; 2011 Feb; 114(2):391-400. PubMed ID: 21245739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of celecoxib on human chondrocytes--enhanced production of chemokines.
    Nakamura H; Masuko K; Yudoh K; Kato T; Nishioka K
    Clin Exp Rheumatol; 2007; 25(1):11-6. PubMed ID: 17417984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical inquiries. Do COX-2 inhibitors worsen renal function?
    Wall R; Strickland C; Jamieson B; Lo V
    J Fam Pract; 2007 Nov; 56(11):957-8. PubMed ID: 17976347
    [No Abstract]   [Full Text] [Related]  

  • 19. Compositions for treatment of cancer and inflammation.
    Lev-Ari S; Lichtenberg D; Arber N
    Recent Pat Anticancer Drug Discov; 2008 Jan; 3(1):55-62. PubMed ID: 18289124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of celecoxib, a COX-2 selective inhibitor.
    Antoniou K; Malamas M; Drosos AA
    Expert Opin Pharmacother; 2007 Aug; 8(11):1719-32. PubMed ID: 17685888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.